- Home
- TRS vs VCEL Comparison
TRS vs VCEL Comparison
Compare TRS & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- VCEL
- Stock Information
- Founded
- TRS 1986
- VCEL 1989
- Country
- TRS United States
- VCEL United States
- Employees
- TRS N/A
- VCEL N/A
- Industry
- TRS Industrial Specialties
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRS Industrials
- VCEL Health Care
- Exchange
- TRS Nasdaq
- VCEL Nasdaq
- Market Cap
- TRS 1.5B
- VCEL 1.6B
- IPO Year
- TRS 2007
- VCEL 1997
- Fundamental
- Price
- TRS $37.02
- VCEL $34.88
- Analyst Decision
- TRS Strong Buy
- VCEL Strong Buy
- Analyst Count
- TRS 2
- VCEL 6
- Target Price
- TRS $45.00
- VCEL $58.60
- AVG Volume (30 Days)
- TRS 359.9K
- VCEL 564.5K
- Earning Date
- TRS 10-28-2025
- VCEL 11-06-2025
- Dividend Yield
- TRS 0.43%
- VCEL N/A
- EPS Growth
- TRS 68.70
- VCEL 2045.40
- EPS
- TRS 1.08
- VCEL 0.13
- Revenue
- TRS $1,013,740,000.00
- VCEL $249,119,000.00
- Revenue This Year
- TRS $11.03
- VCEL $18.35
- Revenue Next Year
- TRS $6.91
- VCEL $22.26
- P/E Ratio
- TRS $34.27
- VCEL $261.17
- Revenue Growth
- TRS 11.83
- VCEL 16.13
- 52 Week Low
- TRS $19.33
- VCEL $29.24
- 52 Week High
- TRS $40.34
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- TRS 44.57
- VCEL 50.89
- Support Level
- TRS $35.10
- VCEL $35.47
- Resistance Level
- TRS $40.30
- VCEL $36.95
- Average True Range (ATR)
- TRS 1.30
- VCEL 1.53
- MACD
- TRS 0.06
- VCEL 0.20
- Stochastic Oscillator
- TRS 36.92
- VCEL 62.69
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.